Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
BURLINGTON, Mass., Feb. 28, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in seven investor conferences in March.
Steven Chehames, Investor Relations, will participate in the 2018 BTIG Healthcare Conference on Thursday, March 1, 2018 in Snowbird, UT.
George LeMaitre, Chairman & CEO, is scheduled to present at the 30th Annual ROTH Conference on Tuesday, March 13, 2018 at the Ritz-Carlton Hotel in Laguna Niguel, CA. The Company’s presentation is scheduled to begin at 10:00 AM PDT.
David Roberts, President, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018 at the Loews Miami Beach Hotel in Miami Beach, FL. The Company’s presentation is scheduled to begin at 11:15 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Morgan Stanley Healthcare Corporate Access Day on Tuesday, March 20, 2018 at the Boston Harbor Hotel in Boston, MA.
David Roberts, President, is scheduled to present at the Oppenheimer Annual Healthcare Conference on Wednesday, March 21, 2018 at the Westin New York Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 3:55 PM EDT.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Needham Healthcare Conference on Wednesday, March 28, 2018 at the Westin New York Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Sidoti Spring Conference on Thursday, March 29, 2018 at the NYC Marriott Marquis Hotel in New York City. The Company’s presentation is scheduled to begin at 3:50 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
